Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”


HHS - 799 - Board of Scientific Counselors of the National Heart, Lung, and Blood Institute - Authorized by Law
Hide Section - GENERAL INFORMATION

GENERAL INFORMATION

Committee NameBoard of Scientific Counselors of the National Heart, Lung, and Blood InstituteAgency NameDepartment of Health and Human Services
Fiscal Year2022Committee Number799
Original Establishment Date11/20/1985Committee StatusChartered
Actual Termination Date Committee URLhttps://www.nhlbi.nih.gov/about/advisory-and-pe...
New Committee This FYNoPresidential Appointments*No
Terminated This FYNoMax Number of Members*11
Current Charter Date4/26/1991Designated Fed Officer Position Title*Associate Scientific Director, Division of Intramural Research
Date Of Renewal Charter Designated Federal Officer Prefix
Projected Termination Date Designated Federal Officer First Name*Robert
Exempt From Renewal*YesDesignated Federal Officer Middle NameS
Specific Termination AuthorityDesignated Federal Officer Last Name*Balaban
Establishment Authority*Authorized by LawDesignated Federal Officer SuffixPhD
Specific Establishment Authority*42 U.S.C. 282(b)(16)Designated Federal Officer Phone*(301) 496-2116
Effective Date Of Authority*11/20/1985Designated Federal Officer Fax*(301) 480-5775
Exempt From EO 13875 Discretionary CmteNot ApplicableDesignated Federal Officer Email*balabanr@nhlbi.nih.gov
Committee Type*Continuing
Presidential*No
Committee Function*Other Committee
Hide Section - RECOMMENDATION/JUSTIFICATIONS

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*Continue
Legislation to Terminate RequiredNot Applicable
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*The BSC scientific review process is largely a retrospective review that focuses on the investigator’s scientific accomplishments over the last four years. Additional emphasis is placed on the overall research program for its distinctive quality, impact, long-term objectives, originality of thought as well as the current and future applications of innovative scientific approaches. The 2022 BSC Virtual Site Visit Review took place on April 25-26, 2022. The Board assessed program developments, accomplishments, future plans and recommendations from previous reviews and provided a written report of the evaluation. Final recommendations were made to the Scientific Director at the BSC Meeting on June 6, 2022.

For the 2022 scientific review, the Board reviewed a total of 11 Senior Investigators and 6 Tenure-Track Investigators from the Cardiovascular Branch (1), Cell and Developmental Biology Center (9), Cellular and Molecular Therapeutics Branch (1), Population Sciences Branch (2), Systems Biology Center (1), Translational Vascular Medicine Branch (1) and NIMHD’s DIR (2). Each investigator gave a 30-minute oral presentation followed by a rigorous 20-minute question and answer session. In addition, the Board reviewed nine Core Directors and three Program Directors at the 2022 BSC Meeting on June 3, 2022.
How is membership balanced?*The Board consists of members who are outstanding authorities knowledgeable in the specialized fields of basic science and clinical medicine related to research activities in the National Heart, Lung, and Blood Institute (NHLBI). The advisory role of the Board is scientific and substantive. The Board, through periodic visits to the laboratories, assesses the research in progress and evaluates productivity and performance of staff scientists.
How frequent & relevant are cmte mtgs?*The Board holds one Site Visit meeting and one BSC meeting per year. These typically take place in April and June, respectively. The Site Visit meeting is a retrospective scientific review of an investigator’s research program and takes place in the spring of each review cycle. Teams of external ad hoc reviewers provide their expertise and consult with the Board members for each investigator under review. During the June meeting, emphasis is focused on results of the prior review, future scientific review processes and recommendations for current research programs. Due to increase demand stemming from the pandemic, FY2021's Site Visit meetings increased in schedule. As a result, the BSC conducted three site visit reviews, two in April, 2021 and one prior to the BSC meeting in June, 2022.
Why advice can't be obtained elsewhere?*The Board of Scientific Counselors is composed of acclaimed biomedical research authorities from outside the NIH. Their recommendations are invaluable because they are considered unbiased, fair and objective. The NHLBI Scientific Director relies on their scores and recommendations to guide resource allocation decisions in NHLBI’s intramural research programs.
Why close or partially close meetings?The meeting of the Board was closed for the review, discussion, and evaluation of individual programs and projects conducted by the National Heart, Lung, and Blood Institute, including consideration of personnel qualifications and performance, the competence of individual investigators, and similar items, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Section 552b(c)(6) of the Government in the Sunshine Act permits the closing of meetings where discussion could reveal personal information, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Recommendation RemarksOther: Scientific and Technical Peer Review.

Chair: Dr. Jodi Nunnari was reassigned as Chair beginning 07/01/2022 through 06/30/2024.

Dr. Jean Schwarzbauer’s membership was incorrectly reported with a 2024 end date on the 2021 report. Their term’s end date has been updated to 2025 on this year’s report.

Two members rotated-off (Bers and Abkowitz) and two were on-boarded (Silverman and Malek). Two vacancies remain due to declinations. This is why the Charter states 11 potential members, but this ACR lists 9.

Reports: This committee did not produce any public reports.

The DFO and the Committee Decision Maker positions are held by the same individual based on assigned duties within the Institute.
Hide Section - PERFORMANCE MEASURES

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*NoAction Reorganize Priorities*Yes
Outcome Trust In GovernmentNoAction Reallocate ResourcesYes
Outcome Major Policy ChangesNoAction Issued New RegulationsNo
Outcome Advance In Scientific ResearchYesAction Proposed LegislationNo
Outcome Effective Grant MakingNoAction Approved Grants Or Other PaymentsNo
Outcome Improved Service DeliveryNoAction OtherNo
Outcome Increased Customer SatisfactionNoAction CommentThe Scientific Director and other NIH officials use the recommendations made by the BSC in evaluating the quality of the intramural research priorities and resources available.
Outcome Implement Laws/Reg RequirementsNoGrants Review*No
Outcome OtherNoNumber Of Grants Reviewed0
Outcome CommentNANumber Of Grants Recommended0
Cost Savings*Unable to DetermineDollar Value Of Grants Recommended$0.00
Cost Savings CommentNIH supported basic and clinical research accomplishments often take many years to unfold into new diagnostic tests and new ways to treat and prevent diseases.Grants Review CommentAlthough grant reviews are included in the duties of this Board, there were no grant reviews performed during this fiscal year.
Number Of Recommendations*243Access Contact Designated Fed. Officer*Yes
Number Of Recommendations Comment29 Total (17 Principal Investigators, 9 Core Directors, 3 Program Directors).Access Agency WebsiteYes
% of Recs Fully Implemented*0.00%Access Committee WebsiteYes
% of Recs Fully Implemented CommentAdditional information is available through the RePORT (Research Portfolio Online Reporting Tool) website. RePORT provides access to reports, data, and analyses of NIH research activities that advance the mission of the NIH, including information on NIH expenditures, strategic plans, reports on NIH funding, and reports on the organization and people involved in NIH research and research training. The RePORT website is located at http://report.nih.gov.Access GSA FACA WebsiteYes
% of Recs Partially Implemented*0.00%Access PublicationsNo
% of Recs Partially Implemented CommentAdditional information is available through the RePORT (Research Portfolio Online Reporting Tool) website. RePORT provides access to reports, data, and analyses of NIH research activities that advance the mission of the NIH, including information on NIH expenditures, strategic plans, reports on NIH funding, and reports on the organization and people involved in NIH research and research training. The RePORT website is located at http://report.nih.gov.Access OtherNo
Agency Feedback*YesAccess CommentContact the Designated Federal Officer.
Agency Feedback Comment*Information resulting from closed Board of Scientific Counselor meetings is subject to the Freedom of Information Act. The public can view information on NIH Intramural Research Reports found on the NIH Intramural Research Sourcebook website located at the https://oir.nih.gov/sourcebook/intramural-research-communications-resources/annual-reports-bibliographies/.Narrative Description*The goal of NIH research is to acquire new knowledge to help prevent, detect, diagnose, and treat disease and disability, from the rarest genetic disorder to the common cold. The NIH mission is to uncover new knowledge that will lead to better health for everyone. NIH works toward that mission by conducting research in its own laboratories. "Section 402(b)(9) of the Public Health Service Act states that “the Director, NIH...shall assure that research at...the National Institutes of Health is subject to review in accordance with section 492.” Section 492(b) states that the “Director of NIH shall establish procedures for periodic technical and scientific peer review of research at the National Institutes of Health. The mission of the Board of Scientific Counselors is to assess the quality of the Institute’s intramural research programs and to evaluate the productivity and performance of intramural scientists and shall also, as requested by the Director, NIH, undertake peer review of extramural funding applications as required by section 492 of the Public Health Service Act, as amended.” This Board assesses the quality of the Institute intramural research programs and evaluates the productivity and performance of staff scientists, necessary functions for the operation of a highly effective intramural research program.
Hide Section - COSTS

COSTS

Payments to Non-Federal Members*$5,600.00Est Payments to Non-Fed Members Next FY*$5,600.00
Payments to Federal Members*$0.00Est. Payments to Fed Members Next FY*$0.00
Payments to Federal Staff*$242,366.00Estimated Payments to Federal Staff*$132,842.00
Payments to Consultants*$9,000.00Est. Payments to Consultants Next FY*$9,000.00
Travel Reimb. For Non-Federal Members*$0.00Est Travel Reimb Non-Fed Members nextFY*$6,451.00
Travel Reimb. For Federal Members*$0.00Est Travel Reimb For Fed Members*$0.00
Travel Reimb. For Federal Staff*$0.00Est. Travel Reimb to Fed Staff Next FY*$0.00
Travel Reimb. For Consultants*$0.00Est Travel Reimb to Consultants Next FY*$11,254.00
Other Costs$7,739.00Est. Other Costs Next FY*$7,816.00
Total Costs$264,705.00Est. Total Next FY*$172,963.00
Date Cost Last Modified9/6/2022 9:41 AMEst. Fed Staff Support Next FY*0.50
Federal Staff Support (FTE)*0.70Est Cost RemarksMeetings were held virtually in FY22 due to the ongoing COVID-19 pandemic. Projected costs for FY23 were increased in the event that in-person/hybrid meetings
resume.

Federal Staff Payments is noticeably less for FY23 projections due to anticipated retirement of senior staff in the year ahead.
Cost RemarksThere are no TC or videoconference costs because arrangements were made through an office-wide Zoom/WebEx account. Therefore, this expense is not part of the operational costs of the committee for this year.  
Hide Section - Interest Areas

Interest Areas

Category
Area
Health
Treatment
Health Care
Medicine
Health and Health Research
Hide Section - MEMBERS,MEETINGS AND ADVISORY REPORTS

MEMBERS,MEETINGS AND ADVISORY REPORTS

To View all the members, meetings and advisory reports for this committee please click here
Hide Section - CHARTERS AND RELATED DOCS

CHARTERS AND RELATED DOCS

No Documents Found
Hide Section - DATA FROM PREVIOUS YEARS

DATA FROM PREVIOUS YEARS

Committee

Data from Previous Years

 
ActionCommittee System IDCommittee NameFiscal Year
 COM-040416Board of Scientific Counselors of the National Heart, Lung, and Blood Institute2021
 COM-038691Board of Scientific Counselors of the National Heart, Lung, and Blood Institute2020
 COM-036565Board of Scientific Counselors of the National Heart, Lung, and Blood Institute2019
 COM-034773Board of Scientific Counselors of the National Heart, Lung, and Blood Institute2018
 COM-002065Board of Scientific Counselors of the National Heart, Lung, and Blood Institute2017
 COM-002595Board of Scientific Counselors of the National Heart, Lung, and Blood Institute2016
 COM-004162Board of Scientific Counselors of the National Heart, Lung, and Blood Institute2015
 COM-004769Board of Scientific Counselors of the National Heart, Lung, and Blood Institute2014
 COM-006229Board of Scientific Counselors of the National Heart, Lung, and Blood Institute2013
 COM-006634Board of Scientific Counselors of the National Heart, Lung, and Blood Institute2012
 COM-007940Board of Scientific Counselors of the National Heart, Lung, and Blood Institute2011
 COM-008830Board of Scientific Counselors of the National Heart, Lung, and Blood Institute2010
 COM-010255Board of Scientific Counselors of the National Heart, Lung, and Blood Institute2009
 COM-010775Board of Scientific Counselors of the National Heart, Lung, and Blood Institute2008
 COM-012194Board of Scientific Counselors of the National Heart, Lung, and Blood Institute2007
 COM-012620Board of Scientific Counselors of the National Heart, Lung, and Blood Institute2006
 COM-013721Board of Scientific Counselors of the National Heart, Lung, and Blood Institute2005
 COM-014414Board of Scientific Counselors of the National Heart, Lung, and Blood Institute2004
 COM-015902Board of Scientific Counselors of the National Heart, Lung, and Blood Institute2003
 COM-016787Board of Scientific Counselors of the National Heart, Lung, and Blood Institute2002
 COM-017713Board of Scientific Counselors of the National Heart, Lung, and Blood Institute2001
 COM-018478Board of Scientific Counselors of the National Heart, Lung, and Blood Institute2000
 COM-019790Board of Scientific Counselors of the National Heart, Lung, and Blood Institute1999
 COM-020292Board of Scientific Counselors, National Heart, Lung, and Blood Institute1998
 COM-021739Board of Scientific Counselors, National Heart, Lung, and Blood Institute1997